| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Common Stock | Options Exercise | $85,799 | +1,666 | +44% | $51.50 | 5,417 | 27 Oct 2021 | Direct | F1 |
| transaction | TNDM | Common Stock | Options Exercise | $19,597 | +238 | +4.4% | $82.34 | 5,655 | 27 Oct 2021 | Direct | F1 |
| transaction | TNDM | Common Stock | Sale | $248,167 | -1,904 | -34% | $130.34 | 3,751 | 27 Oct 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Stock Option | Options Exercise | $85,799 | -1,666 | -5.9% | $51.50 | 26,667 | 27 Oct 2021 | Common Stock | 1,666 | $51.50 | Direct | F3, F4 |
| transaction | TNDM | Stock Option | Options Exercise | $19,597 | -238 | -3.1% | $82.34 | 7,386 | 27 Oct 2021 | Common Stock | 238 | $82.34 | Direct | F4, F5 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock received upon exercise of a stock option award. |
| F2 | The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. |
| F3 | The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
| F4 | The expiration date for these options is 10 years from the date of grant. |
| F5 | The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. |